Status:

RECRUITING

Brain Health in Breast Cancer Survivors

Lead Sponsor:

Jonsson Comprehensive Cancer Center

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Cognitive Impairment

Cognitive Function

Eligibility:

FEMALE

35-65 years

Brief Summary

Endocrine therapy (ET) is widely used to treat hormone receptor positive breast cancer and prevent recurrence by downregulating estrogen function. However, ETs readily cross the blood brain barrier an...

Detailed Description

Endocrine therapy (ET) is widely used to treat hormone receptor positive breast cancer and prevent recurrence by downregulating estrogen function. However, ETs readily cross the blood brain barrier an...

Eligibility Criteria

Inclusion

  • Age 35-65
  • Fluent in English
  • Adequate vision/hearing to complete testing

Exclusion

  • History of major or mild neurocognitive disorder or dementia
  • Diagnosis of major neurological condition (e.g., epilepsy, Parkinson's Disease, stroke)
  • Diagnosis of a major psychiatric disorder (e.g., bipolar disorder, schizophrenia)
  • Untreated/unstable unipolar depression or anxiety
  • Prior history of cancer or chemotherapy (for controls, any history)
  • History of a learning disorder
  • History of head injury with loss of consciousness \>20 minutes
  • History of salpingo-oophorectomy or hysterectomy
  • A cardiac pacemaker
  • Implanted electronic device
  • Claustrophobia
  • Currently pregnant
  • Orbital metal implant or other metallic foreign bodies
  • Additional exclusion criteria for controls: current use of a contraceptive agent that interferes with endogenous hormonal fluctuation (e.g., oral contraceptive pill) or precludes determination of menstrual pattern (e.g., hormonally secreting intrauterine device), or current treatment with systemic estrogen replacement therapy.

Key Trial Info

Start Date :

March 11 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 15 2027

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT04297020

Start Date

March 11 2020

End Date

March 15 2027

Last Update

May 13 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of California at Los Angeles

Los Angeles, California, United States, 90095

Brain Health in Breast Cancer Survivors | DecenTrialz